Multi-target novel neuroprotective compound ITH33/IQM9.21 inhibits calcium entry, calcium signals and exocytosis
dc.contributor.author | Maroto, Marcos | |
dc.contributor.author | Diego, Antonio M. G. de | |
dc.contributor.author | Albinana, Elisa | |
dc.contributor.author | Fernandez-Morales, Jose C. | |
dc.contributor.author | Caricati-Neto, Afonso [UNIFESP] | |
dc.contributor.author | Jurkiewicz, Aron [UNIFESP] | |
dc.contributor.author | Yanez, Matilde | |
dc.contributor.author | Isabel Rodriguez-Franco, Maria | |
dc.contributor.author | Conde, Santiago | |
dc.contributor.author | Arce, Mariana P. | |
dc.contributor.author | Hernandez-Guijo, Jesus M. | |
dc.contributor.author | Garcia, Antonio G. | |
dc.contributor.institution | Univ Autonoma Madrid | |
dc.contributor.institution | CSIC | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Univ Santiago de Compostela | |
dc.date.accessioned | 2016-01-24T14:17:16Z | |
dc.date.available | 2016-01-24T14:17:16Z | |
dc.date.issued | 2011-10-01 | |
dc.description.abstract | Compound ITH33/IQM9.21 (ITH/IQM) belongs to a new family of L-glutamic acid derivatives with antioxidant and neuroprotective properties on in vitro and in vivo models of stroke. Because neuronal damage after brain ischemia is tightly linked to excess Ca2+ entry and neuronal Ca2+ overload, we have investigated whether compound ITH/IQM antagonises the elevations of the cytosolic Ca2+ concentrations ([Ca2+](c)) and the ensuing exocytotic responses triggered by depolarisation of bovine chromaffin cells. in fluo-4-loaded cell populations, ITH/IQM reduced the K+-evoked [Ca2+](c) transients with an IC50 of 5.31 mu M. At 10 mu M, the compound decreased the amplitude and area of the Ca2+ transient elicited by challenging single fura-2-loaded cells with high K+ by 40% and 80%, respectively. This concentration also caused a blockade of K+-induced catecholamine release at the single-cell level (78%) and cell populations (55%). These effects are likely due to blockade of the whole-cell inward Ca2+ currents (IC50 = 6.52 mu M). At 10 mu M, ITH/IQM also inhibited the Ca2+-dependent outward K+ current, leaving untouched the voltage-dependent component of I-K. the inward Na+ current was unaffected. Inhibition of depolarisation-elicited Ca2+ entry, [Ca2+](c) elevation and exocytosis could contribute to the neuroprotective effects of ITH/IQM in vulnerable neurons undergoing depolarisation during brain ischemia. (C) 2011 Elsevier B.V. All rights reserved. | en |
dc.description.affiliation | Univ Autonoma Madrid, Fac Med, Inst Teofilo Hernando, E-28029 Madrid, Spain | |
dc.description.affiliation | Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, E-28029 Madrid, Spain | |
dc.description.affiliation | CSIC, Inst Quim Med, E-28006 Madrid, Spain | |
dc.description.affiliation | Universidade Federal de São Paulo, Dept Farmacol, Escola Paulista Med, São Paulo, Brazil | |
dc.description.affiliation | Univ Santiago de Compostela, Fac Farm, Dept Farmacol, Santiago de Compostela, Spain | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Dept Farmacol, Escola Paulista Med, São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Consolider Program Ingenio-2010 | |
dc.description.sponsorship | Ministerio de Ciencia e Innovacion, Spain | |
dc.description.sponsorship | Instituto de Salud Carlos III, Fundacion CIEN Ministerio de Ciencia e Innovacion, Spain | |
dc.description.sponsorship | Comunidad Autonoma de Madrid, Spain | |
dc.description.sponsorship | Agencia Lain Entralgo, Madrid, Spain | |
dc.description.sponsorship | UAM-CEAL-Banco Santander | |
dc.description.sponsorshipID | Consolider Program Ingenio-2010: SAF 2006-03589 | |
dc.description.sponsorshipID | Ministerio de Ciencia e Innovacion, Spain: SAF 2010-21795 | |
dc.description.sponsorshipID | Ministerio de Ciencia e Innovacion, Spain: SAF 2006/01249 | |
dc.description.sponsorshipID | Ministerio de Ciencia e Innovacion, Spain: SAF 2009-13015-C02-01 | |
dc.description.sponsorshipID | Instituto de Salud Carlos III, Fundacion CIEN Ministerio de Ciencia e Innovacion, Spain: PIO 16/09 | |
dc.description.sponsorshipID | Comunidad Autonoma de Madrid, Spain: SAL2006/02751 | |
dc.description.sponsorshipID | Agencia Lain Entralgo, Madrid, Spain: NDE 07/09 | |
dc.format.extent | 359-369 | |
dc.identifier | http://dx.doi.org/10.1016/j.ceca.2011.06.006 | |
dc.identifier.citation | Cell Calcium. Edinburgh: Churchill Livingstone, v. 50, n. 4, p. 359-369, 2011. | |
dc.identifier.doi | 10.1016/j.ceca.2011.06.006 | |
dc.identifier.issn | 0143-4160 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/34103 | |
dc.identifier.wos | WOS:000296683800005 | |
dc.language.iso | eng | |
dc.publisher | Churchill Livingstone | |
dc.relation.ispartof | Cell Calcium | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | ITH33/IQM9.21 | en |
dc.subject | Calcium channels | en |
dc.subject | Calcium-dependent potassium channels | en |
dc.subject | Calcium signalling | en |
dc.subject | Exocytosis | en |
dc.title | Multi-target novel neuroprotective compound ITH33/IQM9.21 inhibits calcium entry, calcium signals and exocytosis | en |
dc.type | info:eu-repo/semantics/article |